Hyperion Therapeutics Secures $17,471,998 New Funding Round

  • Feed Type
  • Date
  • Company Name
    Hyperion Therapeutics
  • Mailing Address
    601 Gateway Blvd South San Francisco, CA 94080
  • Company Description
    Hyperion Therapeutics, Inc. is a privately held specialty biopharmaceutical company dedicated to improving patients’ lives through the development and commercialization of therapies that address critical unmet needs and underserved patient populations. The Company’s initial efforts are focused in the areas of gastroenterology and hepatology.
  • Website
  • Transaction Type
    Debt, Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. Amount may include options, warrants or other rights to acquire other securities. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy